152 related articles for article (PubMed ID: 38462643)
1. Genetic diversity of variants involved in drug response among Tunisian and Italian populations toward personalized medicine.
Jmel H; Sarno S; Giuliani C; Boukhalfa W; Abdelhak S; Luiselli D; Kefi R
Sci Rep; 2024 Mar; 14(1):5842. PubMed ID: 38462643
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations.
Jmel H; Romdhane L; Ben Halima Y; Hechmi M; Naouali C; Dallali H; Hamdi Y; Shan J; Abid A; Jamoussi H; Trabelsi S; Chouchane L; Luiselli D; Abdelhak S; Kefi R
PLoS One; 2018; 13(4):e0194842. PubMed ID: 29652911
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China.
Yan M; Li D; Zhao G; Li J; Niu F; Li B; Chen P; Jin T
Gene; 2018 Mar; 648():54-62. PubMed ID: 29337087
[TBL] [Abstract][Full Text] [Related]
4. Genetic diversity of 'Very Important Pharmacogenes' in two South-Asian populations.
Bharti N; Banerjee R; Achalere A; Kasibhatla SM; Joshi R
PeerJ; 2021; 9():e12294. PubMed ID: 34824904
[TBL] [Abstract][Full Text] [Related]
5. Ethnic and functional differentiation of copy number polymorphisms in Tunisian and HapMap population unveils insights on genome organizational plasticity.
Romdhane L; Kefi S; Mezzi N; Abassi N; Jmel H; Romdhane S; Shan J; Chouchane L; Abdelhak S
Sci Rep; 2024 Feb; 14(1):4654. PubMed ID: 38409353
[TBL] [Abstract][Full Text] [Related]
6. VKORC1 polymorphisms in Brazilians: comparison with the Portuguese and Portuguese-speaking Africans and pharmacogenetic implications.
Suarez-Kurtz G; Amorim A; Damasceno A; Hutz MH; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Prata MJ; Ribeiro-dos-Santos A; Romano-Silva MA; Teixeira D; Struchiner CJ
Pharmacogenomics; 2010 Sep; 11(9):1257-67. PubMed ID: 20860466
[TBL] [Abstract][Full Text] [Related]
7. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.
Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS
Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801
[TBL] [Abstract][Full Text] [Related]
8. Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.
Giri AK; Khan NM; Grover S; Kaur I; Basu A; Tandon N; Scaria V; ; ; Kukreti R; Brahmachari SK; Bharadwaj D
Pharmacogenomics; 2014 Jul; 15(10):1337-54. PubMed ID: 25155935
[TBL] [Abstract][Full Text] [Related]
9. Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians.
Borgiani P; Ciccacci C; Forte V; Romano S; Federici G; Novelli G
Pharmacogenomics; 2007 Nov; 8(11):1545-50. PubMed ID: 18034619
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.
Dandara C; Lombard Z; Du Plooy I; McLellan T; Norris SA; Ramsay M
Pharmacogenomics; 2011 Dec; 12(12):1663-70. PubMed ID: 22118051
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of pharmacogenetic variants of vitamin K epoxide reductase complex subunit 1 gene (rs9923231), cytochrome P450 family 2 subfamily C member 9 gene (rs1799853) and cytochrome P450 family 3 subfamily-A member-5 gene (rs776746) among 13 ethnic groups of Pakistan.
Firasat S; Raza A; Khan AR; Abid A
Mol Biol Rep; 2023 May; 50(5):4017-4027. PubMed ID: 36849858
[TBL] [Abstract][Full Text] [Related]
12. Genetic landscape of forensic DNA phenotyping markers among Mediterranean populations.
Becher D; Jmel H; Kheriji N; Sarno S; Kefi R
Forensic Sci Int; 2024 Jan; 354():111906. PubMed ID: 38128201
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in very important pharmacogenomic (VIP) variants in the Tibetan population.
Jin TB; Xun XJ; Shi XG; Yuan DY; Feng T; Geng TT; Kang LL
Genet Mol Res; 2015 Oct; 14(4):12497-504. PubMed ID: 26505400
[TBL] [Abstract][Full Text] [Related]
14. Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population.
Mitchell C; Gregersen N; Krause A
Pharmacogenomics; 2011 Jul; 12(7):953-63. PubMed ID: 21635147
[TBL] [Abstract][Full Text] [Related]
15. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
[TBL] [Abstract][Full Text] [Related]
16. A genome wide SNP genotyping study in the Tunisian population: specific reporting on a subset of common breast cancer risk loci.
Hamdi Y; Ben Rekaya M; Jingxuan S; Nagara M; Messaoud O; Benammar Elgaaied A; Mrad R; Chouchane L; Boubaker MS; Abdelhak S; Boussen H; Romdhane L
BMC Cancer; 2018 Dec; 18(1):1295. PubMed ID: 30594178
[TBL] [Abstract][Full Text] [Related]
17. Genotype frequencies of VKORC1 and CYP2C9 in native and Mestizo populations from Mexico, potential impact for coumarin dosing.
Villegas-Torres B; Sánchez-Girón F; Jaramillo-Villafuerte K; Soberón X; Gonzalez-Covarrubias V
Gene; 2015 Mar; 558(2):235-40. PubMed ID: 25560189
[TBL] [Abstract][Full Text] [Related]
18. Analytical validation of GenoPharm a clinical genotyping open array panel of 46 pharmacogenes inclusive of variants unique to people of African ancestry.
Kanji CR; Mbavha BT; Masimirembwa C; Thelingwani RS
PLoS One; 2023; 18(10):e0292131. PubMed ID: 37788265
[TBL] [Abstract][Full Text] [Related]
19. Susceptiveness of Vitamin K epOxide Reductase Complex Subunit 1 Gene Polymorphism in Essential Hypertension.
Turgut Cosan D; Yazıcı HU; Colak E; Soyocak A; Degirmenci I; Kurt H; Birdane A; Colak E; Gunes HV
Genet Test Mol Biomarkers; 2017 May; 21(5):292-297. PubMed ID: 28281786
[TBL] [Abstract][Full Text] [Related]
20. Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations.
El Rouby N; Shahin MH; Bader L; Khalifa SI; Elewa H
Clin Transl Sci; 2022 Feb; 15(2):558-566. PubMed ID: 34729928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
